Rezon Bio is attending the PharmaSource External Manufacturing Leaders edition in Basel, featuring interactive and educative sessions on AI in external manufacturing and mitigating risk across external networks in 2026.
Published
Signal category
Presence & Recognition
Quote
“Looking forward to interactive and educative sessions at this years PharmaSource External Manufacturing Leaders edition today in Basel.”
— Fabian Friedl|Rezon Bio team
Company
Rezon Bio
Where Dedication Delivers Biologics
- Industry
- Biotechnology Research
- Location
- Gdansk, PL
- Company size
- 723 employees
Rezon Bio is a science-driven contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian biologics. Headquartered in Poland, Rezon Bio offers integrated solutions spanning cell line development, commercial drug substance manufacturing, and drug product development. The company operates with state-of-the-art facilities, world-class teams, and a proven track record of regulatory and commercial success. Drawing on a legacy of biosimilars development and global commercialization, Rezon Bio combines experience, digital transparency, and cost-to-value efficiency to help clients move from concept to market with confidence.